ArticleFrontiers in psychiatry2026
Global, regional, and national burden of schizophrenia: epidemiological trends, decomposition, joinpoint analysis, and projections to 2036 based on GBD 2021.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Schizophrenia continues to impose a substantial burden within the global spectrum of disease. This study utilizes the most recent data from the Global Burden of Disease Study 2021 (GBD 2021) to analyze epidemiological trends specific to schizophrenia and generate empirical evidence to guide the development of targeted prevention and clinical management strategies. Methods: Leveraging the GBD 2021 dataset, we examined age-standardized incidence, prevalence, and disability-adjusted life years (DALYs) for schizophrenia. We further evaluated temporal trends and age-sex-specific variations; executed decomposition analysis to identify primary determinants; conducted Joinpoint regression analysis; and generated projections through 2036. Results: In 2021, schizophrenia incidence demonstrated a declining trend, whereas prevalence and DALYs exhibited increasing trends. The burden disproportionately affected younger and middle-aged males, with a concomitant progressive increase observed among females. Significant disparities existed across geographic regions, high-SDI regions exhibited persistently elevated burden with upward trajectories, whereas low-SDI regions demonstrated progressive increases from lower baseline levels. These patterns were primarily attributable to population growth, SDI levels, and epidemiological parameter shifts, while population aging attenuated the schizophrenia burden. Conclusions: While schizophrenia currently exerts a disproportionately higher burden on young and middle-aged males, our projections indicate a notable epidemiological shift, with females expected to experience a steeper rise in incidence, prevalence, and DALYs over the next 15 years. This emerging female-centric trend contrasts sharply with the current male-dominated profile, underscoring the urgent need for sex-responsive mental health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.